A self-amplifying mRNA-based combinatorial immunotherapy for treating colorectal cancer

A basic whole-body bioluminescent and fluorescent in vivo imaging system for small laboratory animals

A combinatorial cancer immunotherapy approach based on selfreplicating RNA 

An mRNA replicon based immunotherapeutic combinational treatment for triple negative breast cancer

Cationic polymers with controlled charge separation for non-viral RNA delivery

Design and pre-clincial evaluation of self-replicating mRNA therapeutics that produce protein drugs under control of small, non-toxic molecules

Efficacy and immunological aspects of self-amplifying (sa) RNA vaccines encoding avian influenza antigens

Enhanced self-amplifying RNA with prolonged protein production and reduced side-effects.

Evaluation of delivery systems for mRNA cancer vaccines

Evaluation of highly immunogenic tumor cell vaccines in combination with regulatory T-cell depletion

Evaluation of immunogenic properties of modified mRNA and self-replicating RNA based vaccines against cancer

gene Therapy

High throughput automatization of cell and organoid based assays for cross-health valorization -Acronym: ACOBA

Introducing mRNA vaccination in chicken: first steps towards a commercial mRNA vaccine against a leading viral infection in chicken

Investigation of the potential of novel cationic polymers as non-viral carriers for RNA-based applications

In vivo evaluation of non-viral mRNA delivery systems for mRNA vaccination against cancer.

Messenger RNA transfected myeoloid-derived suppressor cells as cellular vehicles for tumor-targeted delivery of IL-12

mRNA vaccines and mRNA therapeutics: design, production, delivery and preclinical testing

Novel cationic polymers for RNA vaccination

Self-amplifying RNAs with enhanced properties

Targeted delivery of PEGylated adeno-associated viral vectors

Targeted release of chemotherapeutic agents with ultrasound and microbubbles

The induction of intestinal immunity in a piglet model

West Nile Integrated Shield Project: Epidemiology, Diagnosis and Prevention of West Nile Virus in Europe

Barriers and carriers for non-viral delivery of mRNA to induce transient protein expression in the retina: the hurdles of the inner limiting membrane and innate immunity versus the potential of mRNA self-amplification.

Barriers and carriers for non-viral delivery of mRNA to induce transient protein expression in the retina: the hurdles of the inner limiting membrane and innate immunity versus the potential of mRNA self-amplification.

Biofabrication of vasculature for organ engineering and bypass grafting

BioGelator for local immunotherapy

Chlamydia psittaci DNA vaccination and alternatives

Design of a Chlamydia vaccine

Development of a buccal self-amplifying mRNA vaccine for periodontal disease prophylaxis in dogs.

Doxorubicin-loaded microbubbles for ultrasound controlled destruction of tumor cells

Evaluation of the therapeutic possiblities of siRNA in the treatment of hyperpigmentation of the skin

Novel cationic polymers for sa-mRNA-based protein replacement therapy

Replacement of confocal fluorescence microscope for visualisation of biological processes in humans and animals

RNA synthetic biology for genetic engineering of the first vaccine for companion birds against the underestimated respiratory zoonotic pathogen Chlamydia psittaci

Sonodrugs-image-controlled ultrasound- induced drug delivery

Biopharmaceutical Evaluation of non-viral carriers for the afgite of siRNA in the treatment of hepatitis and liver cancer.